An investigation of the in vivo role of vaccinia virus complement control protein in head injury and Alzheimer's disease
An investigation into the specific function of the vaccinia virus 13.8 kDa protein encoded by the N1
Delivery of Vaccinia Virus Complement Control Protein (VCP) and Curcumin to the rodents' brain : implications in Alzheimer's disease and HIV dementia
An investigation into the specific function of the vaccinia virus :13.8 kDa protein encoded by the N1L gene
In vitro characterization of the antiviral activity of Secomet V against vaccinia virus infections
Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein
Cloning and expression of a functionally active truncated N-glycosylated KSHV complement regulatory protein and immunohistochemical studies with the anti-KCP peptide antibody
A comparative analysis of cowpox virus (CPV WT) and a deletion mutant lacking the gene encoding the inflammation modulatory protein (CPV IMP)
The investigation of histopathological changes after the administration of vaccinia virus complement control protein in brain injured rats
Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
Comparison of the two lumpy skin disease virus vaccines, Neethling and Herbivac, and construction of a recombinant Herbivac-Rift Valley fever virus vaccine
Prokaryotic Production of Human Immunodeficiency VirusType 1 Subtype C Tat, Nef and Reverse Transcriptase andInvestigation of Antibody Responses to these proteins inHIV-1 Infected Individuals as well as Macaques Vaccinatedwith SAAVI DNA-C/C2 and SAAV
Adaptive changes in HIV-1 subtype c proteins during early infection and their effect on disease progression
Characterization of genotypic and phenotypic properties of transmitted Human Immunodeficiency virus type 1 variants circulating in Mbeya Tanzania
An investigation into the Use of Lumpy Skin Disease Virus as a Vaccine Vector for a Potential HIV-1 vaccine
Genetic characterisation of six novel African swine fever viruses isolated from a pig, warthog, wild boar, and ticks
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
A study of host genetic determinants of human papillomavirus (HPV) infection, cervical cancer and herpes simplex virus type-2 (HSV-2) infection
Impact of long-acting contraceptives on female genital tract cytokine profiles in a randomised controlled trial
Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences
The role of early cytotoxic lymphocyte (CTL) escape in the pathogenesis of HIV-1 subtype C infection
Optimisation of the mycobacterial replicon of an E. coli-mycobacterial shuttle vector
Cellular immune responses to human papillomavirus (HPV) type 16 at the cervix of women with HPV-associated squamous intraepithelial neoplasia
Characterisation of HIV-1 Envelope features of breakthrough infections from the CAPRISA 004 Microbicide Trial
